Home > Boards > US OTC > Medical - Healthcare >

Procyon Corporation (PCYN)

PCYN RSS Feed 		Add PCYN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/29/2018 10:16:55 AM - Followers: 6 - Board type: Free - Posts Today: 0

Procyon Corporation (PCYN.OB), through its subsidiaries, engages in the development and marketing of medical products used in the treatment of pressure ulcers, dermatitis, inflammation, and other skin problems in the United States.

Subsidiaries

http://www.amerigel.com/

Share Structure
Common: 8,049,588
Preferred stock (Series A) (One = One Common) : 204,900 and receives Dividend of about $.026/share

Filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000812306
Yahoo: http://finance.yahoo.com/q?s=pcyn.ob

Recent News: http://search.marketwire.com/search/searchsimple.do?keywords=pcyn&newsearch=Y&sortby=date

World Diabetic research Foundation Directors: http://www.wdrf.org/directors.php

Yahoo Link



PROCYON CORPORATION & SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
            
June 30, 2011 and 2010
            
               
               
     
2011
    
2010
  
ASSETS
              
               
CURRENT ASSETS
            
 
Cash
   $ 721,054     $ 827,512  
 
Certificate of Deposits, and accrued interest
     155,142       54,028  
 
Accounts receivable, less allowance for doubtful
                
 
     accounts of $1,000.
     311,493       184,130  
 
Inventories
     204,733       188,287  
 
Prepaid expenses
     147,449       116,815  
 
Other Receivable
     8,762       -  
 
Deferred tax asset
     140,577       121,391  
 
     TOTAL CURRENT ASSETS
     1,689,210       1,492,163  
                   
PROPERTY AND EQUIPMENT, NET
     535,040       513,925  
                   
OTHER ASSETS
                
 
Deposits
     792       1,854  
 
Deferred tax asset
     724,681       861,945  
        725,473       863,799  
                   
TOTAL ASSETS
   $ 2,949,723     $ 2,869,887  
                   
LIABILITIES AND STOCKHOLDERS' EQUITY
                
                   
CURRENT LIABILITIES
                
 
Accounts Payable
   $ 130,453     $ 184,942  
 
Accrued Expenses and Other
     146,753       128,006  
 
Current Portion of Mortgage Payable
     32,211       26,335  
 
     TOTAL CURRENT LIABILITIES
     309,417       339,283  
                   
LONG-TERM LIABILITIES
                
 
Mortgage Payable
     314,173       397,367  
 
     TOTAL LONG TERM LIABILITIES
     314,173       397,367  
                   
STOCKHOLDERS' EQUITY
                
 
Preferred stock, 496,000,000 shares authorized,
                
 
none issued
     -       -  
 
Series A Cumulative Convertible Preferred stock,
                
 
no par value; 4,000,000 shares authorized; 199,100
                
 
shares issued and outstanding
     154,950       154,950  
 
Common stock, no par value, 80,000,000 shares
                
 
authorized; 8,055,388 shares issued and outstanding
     4,416,676       4,416,676  
 
Paid-in Capital
     6,000       6,000  
 
Accumulated deficit
     (2,251,493 )     (2,444,389 )
 
     TOTAL STOCKHOLDERS' EQUITY
     2,326,133       2,133,237  
                   
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
   $ 2,949,723     $ 2,869,887  
                   
                   
The accompanying notes are an integral part of these financial statements.
  
   
 F - 2  

 
 
 


 

PROCYON CORPORATION & SUBSIDIARIES
            
CONSOLIDATED STATEMENTS OF OPERATIONS
            
Years Ended June 30, 2011 and 2010
            
               
     
2011
    
2010
  
               
               
NET SALES
   $ 2,701,996     $ 2,547,365  
                   
COST OF SALES
     596,892       542,793  
                   
GROSS PROFIT
     2,105,104       2,004,572  
                   
OPERATING EXPENSES
                
                   
 
Salaries and Benefits
     951,169       981,870  
 
Selling, General and Administrative
     818,610       840,666  
        1,769,779       1,822,536  
                   
INCOME FROM OPERATIONS
     335,325       182,036  
                   
OTHER INCOME (EXPENSE)
                
 
Interest Income
     2,726       6,664  
 
Other Expense
     (16 )     -  
 
Interest Expense
     (27,633 )     (32,075 )
        (24,923 )     (25,411 )
                   
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
     310,402       156,625  
                   
INCOME TAX (EXPENSE)
     (117,863 )     (58,787 )
                   
NET INCOME FROM CONTINUING OPERATIONS
     192,539       97,838  
                   
DISCONTINUED OPERATIONS
                
 
Income from Operations of Discontinued Component
     573       39,979  
 
Provision for Income Tax (Expense)
     (216 )     (15,044 )
NET INCOME FROM DISCONTINUED OPERATIONS
     357       24,935  
                   
NET INCOME
     192,896       122,773  
                   
Dividend requirements on preferred stock
     (19,910 )     (19,910 )
                   
Basic net income available to common shares
   $ 172,986     $ 102,863  
                   
Basic net income per common share
                
 
Continuing Operations
   $ 0.02     $ 0.01  
 
Discontinued Operations
   $ -     $ -  
Total Basic Net Income Per Share
   $ 0.02     $ 0.01  
                   
Weighted average number of common shares outstanding
     8,055,388       8,055,388  
                   
Diluted net income per common share
                
 
Continuing Operations
   $ 0.02     $ 0.01  
 
Discontinued Operations
   $ -     $ -  
Total Diluted Net Income Per Share
   $ 0.02     $ 0.01  
                   
Weighted average number of common shares
     8,254,488       8,254,488  
 
outstanding, diluted
                
   

 



 
 
 


 

 

 

PCYN
Current Price
Volume:
Bid Ask Day's Range
PCYN Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PCYN News: Quarterly Report (10-q) 05/17/2019 04:36:41 PM
PCYN News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 05/15/2019 04:43:44 PM
PCYN News: Quarterly Report (10-q) 02/14/2019 03:23:10 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#68   Thanks. You could comment on my blog if NoNameStocks 08/29/18 10:16:55 AM
#67   You didn't mention a couple very compelling reasons Lazarus 08/29/18 09:54:15 AM
#66   new writeup on PCYN NoNameStocks 08/29/18 01:26:28 AM
#65   It did. I'm going to sit the bid goarmy123 09/05/14 10:02:01 AM
#64   Just got into 'interesting' territory at .11 First Crown Research 09/04/14 01:28:08 PM
#63   You probably bought some of mine :-). ghmm 10/04/12 03:38:16 PM
#62   Yeah I am. I bought more back btmfdr2 10/04/12 03:18:31 PM
#61   No I am completely out. Sold the ghmm 10/04/12 02:42:35 PM
#60   Another year came and went. Are you btmfdr2 10/04/12 01:57:58 PM
#59   I only had glanced at the Q till ghmm 02/15/12 09:22:26 PM
#58   Well ghmm, it looks like I'm here to btmfdr 02/15/12 02:53:30 PM
#57   Quarterly earnings out. Revenue was a schocker, I btmfdr 11/15/11 11:12:34 PM
#56   Not to create more work for you but ghmm 09/30/11 10:31:25 AM
#55   PYCN.. $0.23.. 10 bagger 09/30/11 12:38:11 AM
#54   PCYN.. 10 bagger 09/30/11 12:13:11 AM
#53   Yeah it would be nice to see them ghmm 09/29/11 06:17:01 PM
#52   Along with expectations of continued revenue growth in btmfdr 09/29/11 03:42:09 PM
#51   Not a bad quarter and year for the ghmm 09/28/11 04:53:07 PM
#50   PCYN.. No updates to report since last post.... 10 bagger 09/14/11 12:31:48 AM
#49   PCYN.. No updates to report since last post.... 10 bagger 08/31/11 03:03:50 PM
#48   I agree about the dividend (I had forgotten ghmm 07/20/11 10:55:36 PM
#47   'Happy with the status quo' was probably not btmfdr 07/20/11 10:47:16 PM
#46   I am not so happy with the status ghmm 07/20/11 08:45:10 PM
#45   Forgot about the preferred ghmm 07/20/11 12:32:39 PM
#44   I dont think we see a dividend anytime btmfdr 07/20/11 11:46:29 AM
#43   PCYN.. I own 17088 and thats it.. Time to 10 bagger 07/19/11 03:59:56 PM
#42   This is hard to read. I am ghmm 07/19/11 03:22:09 PM
#41   FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION 10 bagger 07/19/11 01:19:02 PM
#40   Now that's funny but true... 10 bagger 06/21/11 09:48:07 AM
#39   I didn't know TA applied to stocks that ghmm 06/21/11 09:42:45 AM
#38   PCYN has been showing support around 0.15 and alhigou 06/21/11 09:34:05 AM
#37   Might not mean anything and no big amount ghmm 06/20/11 09:47:51 PM
#36   PCYN.. $0.19 10 bagger 04/18/11 02:29:37 PM
#35   We meet again. I bought some PCYN otcbargains 04/18/11 02:22:40 PM
#34   PCYN.. $0.12 earnings...Cheap.. 10 bagger 02/11/11 11:14:23 AM
#33   Congrats on that one very nice gain. ghmm 02/10/11 06:12:34 PM
#32   I agree! The sales improvment is very btmfdr 02/10/11 06:10:49 PM
#31   At first glance Q looks pretty strong. ghmm 02/10/11 06:01:29 PM
#30   Yes it was me.. Ive been able to 10 bagger 11/16/10 07:52:41 AM
#29   I saw a .1328 bid the other day ghmm 11/16/10 05:44:20 AM
#28   PCYN $0.15 Investor relations.. 10 bagger 11/15/10 11:37:38 PM
#27   Corporate Governance - 10 bagger 11/15/10 11:36:08 PM
#26   PCYN.. $0.15 10Q 10 bagger 11/15/10 11:34:56 PM
#25   Procyon Corp. 10 bagger 11/15/10 11:33:54 PM
#24   Some volume finally! ghmm 05/14/10 10:28:49 AM
#23   The K is out, nothing to get excited ghmm 09/09/08 05:57:19 PM
#22   NEWS... Procyon Corporation Announces Amerx Healthcare Subsidiary Has zsvq1p 05/08/08 05:43:32 PM
#21   brick by brick.... zsvq1p 02/08/08 06:00:30 PM
#20   Great quarter, so much for being able to ghmm 02/08/08 05:21:08 PM
#19   A Nice article on the company though it ghmm 12/30/07 02:18:06 PM
PostSubject
© 2019 InvestorsHub.com, Inc.